References
Jones DM, Eldridge J, Fox AJ, et al. Antibody to the gastric campylobacter-like organism, clinical correlations and distribution in the normal population. J Med Microbiol 1986; 22: 57–62
Perez-Perez GI, Dworkin BM, Chodos JE, et al. Camplyobacter pylori antibodies in humans. Ann Intern Med 1988; 109: 11–7
Kuipers EJ, Pena AS, van Kamp G, et al. Seroconversion for Helicobacter pylori. Lancet 1993; 342: 328–31
Rauws EAJ, Tytgat GNJ. Cure of duodenal ulcer associated with eradication of Helicobacter pylori. Lancet 1990; 335: 1233–5
George LL, Borody TJ, Andrews P, et al. Cure of duodenal ulcer relapse after eradication of Helicobacter pylori. Med J Aust 1990; 153: 145–9
Oderda G, Vaira D, Ainley C, et al. Eighteen months follow-up of Helicobacter pylori positive children treated with amoxycillin and tinidazole. Gut 1992; 33: 1328–30
Drumm B, Perez-Perez G, Blazer M, et al. Intra-familial clustering of Campylobacter pylori infection. N Engl J Med 1990; 312: 359–63
Strickland RG, Mackay R. A reappraisal of the nature and significance of chronic atrophic gastritis. Am J Dig Dis 1973; 8: 436
Marshall BJ, Armstrong JA, McGechnie DB, et al. Attempt to fulfil Koch’s postulates for pyloric Campylobacter. Med J Aust 1985; 142:436–9
O’Riordan TG, Tobin A, O’Morain C. Helicobacter pylori in elderly dyspeptic patients. Age Ageing 1991; 20: 189–92
Morris J, Dew M. Age and gastrointestinal disease. In: Pathy MJ, editor. Principles and practice of geriatric medicine. London: J Wiley and Sons, 1985; 297–352
Nyren O, Adami H, Gustavsson S, et al. Social and economic costs of non-ulcer dyspepsia. Scand J Gastroenterol 1985; 209 (Suppl.): 41–7
Vaira D, Miglioli M, Menegatti M, et al. Endoscopic findings in 296 asymptomatic blood donors according to high levels of IgG to Helicobacter pylori [abstract]. Acta Gastroenterol Belg 1993; 56 (Suppl.): 49
Krag E. The pseudo-ulcer syndrome: a clinical, radiographic and statistical follow-up study of patients with ulcer symptoms but no demonstrable ulcer in the stomach or duodenum. Dan Med Bull 1969; 16: 6–9
Coghlan JG, Gilligan D, Humphries H, et al. Campylobacter pylori and recurrence of duodenal ulcers; a 12 month follow-up study. Lancet 1987; 2: 1109–11
Marshall BJ, Goodwin CS, Warren RJ, et al. Prospective double-blind trial of duodenal ulcer relapse after eradication of Campylobacter pylori. Lancet 1988; 2: 1437–42
Smith AC, Price AB, Boriello P, et al. Acomparison of ranitidine and tripotassium dicitratobismuthate in relapse rates of duodenal ulcer. The role of Campylobacter pylori [abstract]. Gastroenterol 1988; 94: 431
George L, Hyland L, Morgan A, et al. Smoking does not contribute to duodenal ulcer relapse after eradication [abstract]. Gastroenterol 1990; 98: 48
Oderda G, Forni M, Dell’Olio D, et al. Cure of peptic ulcer associated with eradication of Helicobacter pylori. Lancet 1990; 1: 1599
Patchett S, O’Riordan TO, Leen E, et al. A prospective study of Helicobacter pylori eradication in duodenal ulcer [abstract]. Gastroenterol 1990; 98: 104
Hentschel E, Nemec H, Schutze K, et al. Duodenal ulcer recurrences and Helicobacter pylori. Lancet 1991; 338: 569
Hepps KS, Ramirez FC, Lew GM, et al. Treatment of Helicobacter pylori reduces the rate of rebleeding in complicated peptic ulcer disease. Gastrointest Endosc 1992; 38: 234
Dixon MF. Helicobacter pylori and peptic ulceration; histopathological aspects. J Gastroenterol Hepatol 1991; 6: 125–30
Rauws EAJ, Tytgat GNJ, editors. Campylobacter pylori. Amsterdam: W.C. den Ouden BV, 1989: 23–7
Sobala GM, King RFG, Axon ATR, et al. Reflux gastritis in the intact stomach. J Clin Pathol 1990; 43: 303–6
Sobala GM, O’Connor HJ, Dewar EP, et al. Histological consequences of bile reflux on the gastric mucosa, with special reference to intestinal metaplasia. J Clin Pathol. In press
Correa P, Cuello C, Fajardo LF, et al. Diet and gastric cancer: nutritional survey in a high-risk area. J Natl Cancer Inst 1983; 70: 673–8
Tatsuta M, Iishi H, Okuda S. Effect of cigarette smoking on acid-secreting area and intestinal metaplasia in the stomach. Dig Dis Sci 1988; 33: 23–9
Kimura K. Chronological transition of the fundic-pyloric border determined by step-wise biopsy of the lesser and greater curvatures of the stomach. Gastroenterol 1972; 63: 584–92
Tatsuta M, Okuda S. Location, healing and recurrence of gastric ulcers in relation to fundal gastritis. Gastroenterol 1975; 69: 897–902
Niemela S, Sotka M, Seppola K, et al. A double-blind study to compare the efficacy of De-Nol in combination with metro-nidazole versus De-Nol or ranitidine in combination with metronidazole placebo in the treatment of gastric ulcers. Ital J Gastroenterol 1991; 23Suppl. 2: 112
Farah D, Sturrock RD, Russell RI. Peptic ulcer disease in rheumatoid arthritis. Ann Rheum Dis 1988; 47: 478–80
Guarner J, Mohar A, Parsonnet J, et al. The association of Helicobacter pylori with gastric cancer and preneoplastic lesions in Chiapas, Mexico. Cancer 1993; 71: 297–301
Nomura A, Stemmermann GN, Chyou PH, et al. Helicobacter pylori infection and gastric carcinoma among Japanese Americans in Hawaii. N Engl J Med 1991; 325: 1132–6
Forman D, Newell DG, Fullerton F, et al. Association between Helicobacter pylori and the risk of gastric cancer: evidence from a prospective investigation. BMJ 1991; 302: 1302–5
Parsonnet J, Friedman GD, Vandersteen DP, et al. Helicobacter pylori infection and risk of gastric carcinoma. N Engl J Med 1991; 325: 1127–31
Eurogast Study Group. An international association between Helicobacter pylori and gastric cancer. Lancet 1993; 341: 1359–62
Graham DY, Klein PD, Evans DG, et al. Helicobacter pylori: epidemiology, relationship to gastric cancer and the role of infants in transmission. Eur J Gastroenterol Hepatol 1992; 4Suppl. 1: S1–S6
The Gastrointestinal Physiology Working Group. Helicobacter pylori and gastritis in Peruvian patients: relationship to socio-economic level, age and sex. Am J Gastroenterol 1990; 85: 819–23
Sobala GM, Schorah CJ, Sanderson M, et al. Ascorbic acid in the human stomach. Gastroenterology 1989; 97: 357–63
Sobala GM, Pignatelli B, Schorah CJ, et al. Levels of nitrite, nitrate, N-nitroso compounds, ascorbic acid and total bile acids in gastric juice of patients with and without precancerous conditions of the stomach. Carcinogenesis 1991; 12: 193–8
Sobala GM, Schorah CJ, Shires S, et al. Impairment of gastric ascorbic acid concentration by acute Helicobacter pylori infection. Gut 1990; 31: A1180
Sobala GM, Schorah CJ, Shires S, et al. Effect of eradication of Helicobacter pylori on gastric juice ascorbic acid concentrations. Gut 1993; 34: 1038–41
Correa P. A human model of gastric carcinogenesis. Cancer Res 1988; 48: 355–6
Cahill RJ, Beattie S, Hamilton H, et al. Cell proliferation in the progression from normal mucosa to gastric carcinoma. Acta Gastroenterol Belg 1993; 56 (Suppl.): 61
Wotherspoon AC, Oritz-Hidalgo C, Falzon MF, et al. Helicobacter pylori and primary B-cell gastric lymphoma. Lancet 1991; 338: 1175–6
Wotherspoon AC, Doglini C, Diss TC, et al. Regression of primary low grade B-cell gastric lymphoma of mucosa-associated lymphoid tissue type after eradication of Helicobacterpylori. Lancet 1993; 342: 575–7
Borody TJ. Possibilities for Helicobacter pylori suppression/eradication. Eur J Gastroenterol Hepatol 1992; 4Suppl. 2: S37–S40
Chiba N, Hunt RH. Meta-analysis of the efficacy of antibiotic therapy in eradicating Helicobacter pylori. Am J Gastroenterol. In press.
Graham DY, Lew GM, Maluty HM, et al. Factors influencing the eradication of H. pylori with triple therapy. Gastroenterol 1992; 102: 493–6
Labenz J, Gyenes E, Ruhl GH, et al. Amoxycillin-omeprazole treatment for the eradication of Helicobacter pylori. Eur J Gastroenterol Hepatol 1991; 3Suppl. 1: S10
Bayerdorffer E, Mannes GA, Sommer A, et al. High dose omeprazole treatment combined with amoxycillin eradicates Helicobacter pylori. Eur J Gastroenterol Hepatol 1992; 4: 697–702
Wyeth JW, Pounder RE, De Koster E, et al. Ranitidine bismuth citrate with antibiotics for eradication of Helicobacter pylori [abstract]. Gastroenterology 1993; 104: A804
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Buckley, M., Martin, P. & O’Morain, C. Helicobacter pylori Infection. Drugs & Aging 5, 1–7 (1994). https://doi.org/10.2165/00002512-199405010-00001
Published:
Issue Date:
DOI: https://doi.org/10.2165/00002512-199405010-00001